On December 18, 2017, Novartis announced that Gilenya® (fingolimod) was granted breakthrough therapy designation by the United States Food and Drug Administration (FDA) for the treatment of children and adolescents […]
Read News ArticleAuthor: Hoff Communications
Highlights from the 2017 Joint ECTRIMS-ACTRIMS Meeting
MSParis2017 was this year’s joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS). […]
Read News Article
MS Patient Publications for Your Waiting Room
The Multiple Sclerosis Association of America (MSAA) is a national nonprofit organization and a leading resource for the entire MS community, improving lives today through vital services and support. MSAA […]
Read News ArticleNew Publications to Manage Multiple Sclerosis from MSAA
Free Publications Providing Extensive Information Now Available, Including the MS Relapse Toolkit and Understanding Progression in MS The Multiple Sclerosis Association of America (MSAA) has produced two new, free publications, […]
Read News ArticleMSAA Expands MRI Assistance and Helpline Hours
To help meet the escalating demand for MRI assistance, MSAA is pleased to announce new program changes to the MRI Access Fund, which will increase our ability to serve more […]
Read News ArticleThe Motivator: Summer/Fall 2017 – View Digital Edition
View the Digital Version of MSAA’s Publication – The Motivator – Summer/Fall 2017.
Read News ArticleThe Motivator: Summer/Fall 2017 – Download PDF
Download the PDF of MSAA’s Publication: The Motivator – Summer/Fall 2017.
Read News ArticleVehicle Modifications
By Maryann B. Hunsberger Pictured is the author’s lift used to put her scooter in the back of her van, enabling her to ride while sitting in a passenger seat […]
Read News ArticleFDA Approves Two Doses of Generic Copaxone for MS
On October 4, 2017, Mylan announced that two doses of their generic version of Copaxone® (glatiramer acetate) had been approved by the United States Food and Drug Administration (FDA) for […]
Read News Article